CA: A Cancer Journal for Clinicians
Articles in this Issue
Correction to “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline”
Cancer statistics, 2026
ABSTRACT Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer...
Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer
ABSTRACT The hormone receptor (HR)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer subtype accounts for most early and metastatic breast cancer (MBC)...
Correction to “Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs”
Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?
Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐driven therapeutics
Cancer statistics, 2026: Charting a course for a national cancer research agenda
Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs
Abstract The early detection of cutaneous melanoma is critical to survival outcomes. Because less than one half of melanomas in the United States are diagnosed by dermatologists, the...
PORTEC‐3 trial finds that adjuvant chemoradiotherapy significantly improves 10‐year survival for patients with high‐risk endometrial cancer
Researchers use pooled analysis to define a cure in colon cancer
Correction to “Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers”
Global incidence of lip, oral cavity, and pharyngeal cancers: Disparities, determinants, and opportunities for prevention, early detection, and treatment
Bridging the cancer divide: Policy and structural solutions for equity in the United States
American Cancer Society’s Report on the Status of Cancer Disparities in the United States, 2025
Abstract Since 2021, the American Cancer Society has published its biennial report on the status of cancer disparities in the United States. In this 2025 report, the authors provide...
Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
Abstract The therapeutic landscape for renal cell carcinoma (RCC) and urinary tract cancer (UTC) has transformed dramatically, creating complexity in treatment selection and sequenci...
Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review
Abstract Radiotherapy is a cornerstone of modern oncologic care, yet its sequelae can significantly impair survivors' quality of life. Chronic radiation‐induced conditions—including...
Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors
Abstract Interventional radiology (IR) is a rapidly evolving medical field that combines advanced imaging with minimally invasive techniques for both diagnosis and treatment. Interve...
Maintenance therapy after first‐line therapy for ovarian cancer: Quantitative effectiveness
Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline
Abstract This update expands the 2020 American Cancer Society (ACS) cervical cancer screening guideline for average‐risk women and individuals with a cervix who...
Human papillomavirus self‐collection: The long road from scientific evaluation to implementation in screening programs
Screening for cervical cancer
Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022
ABSTRACT Cancers of the lip, oral cavity, and pharynx (LOCP) represent a substantial public health challenge worldwide. Using GLOBOCAN national estimates of inci...
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian...